Financials
Financial year 2025
Gross margin
€ 5.5 million
▼ 5% vs 2024
Profit
Growing€ 2.2 million
▲ 47% vs 2024
Debts
Normal€ 5.1 million
▲ 10% vs 2024
REDPHARMA from Zaventem, company number BE0824819011, closed financial year 2025 with a result of € 2.2 million after tax. For that financial year REDPHARMA recorded a gross margin of € 5.5 million and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 1.5 million to € 2.2 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.
What happened at REDPHARMA?
What happened at REDPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Clotilde Ghysselinckx stepped down as director. NBB
- Emmanuel Vanderhaegen stepped down as director. NBB
- Clément Vanthournhout stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.2 million (▲ 47% vs 2024). Source: NBB ↗
- Emmanuel Vanderhaegen became a director. NBB
- Clotilde Ghysselinckx became a director. NBB
- Clément Vanthournhout became a director. NBB
- New establishment in Hannut. KBO
In short
From € 1.4 million profit in 2021 to € 2.2 million profit in 2025.
Paid € 3.4 million in corporate taxes since 2021.
Best year ever: 2025, with € 2.2 million profit.
On average € 229,700 of value added per employee in 2025.
A new publication or filing at REDPHARMA? We notify you, reason included.
Follow REDPHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by IQVIA Solutions Belgium BVBA (100%).
Directors
According to the 2025 annual accounts
Clotilde Ghysselinckx
Bestuurder
since 2022 · until 2028
Emmanuel Vanderhaegen
Bestuurder
Also active at: IQVIA Solutions Belgium, IQVIA RDS & INTEGRATED SERVICES BELGIUM, FORCEA
since 2023 · until 2028
Clément Vanthournhout
Bestuurder
Also active at: IQVIA Solutions Belgium, IQVIA RDS & INTEGRATED SERVICES BELGIUM, Omni Care Consult +1 more
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 7
1930 Zaventem
Rue Coquiamont (MER) 11
4280 Hannut
Active since 1 September 2016
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
IQVIA Solutions Belgium same network
€ 33.1 million revenue · 2025
TAKEDA BELGIUM
€ 201.4 million revenue · 2025
IQVIA RDS & INTEGRATED SERVICES BELGIUM same network
€ 45.6 million revenue · 2025
IM ASSOCIATES
€ 3.1 million gross margin · 2025
Orifarm Healthcare
€ 31.3 million revenue · 2025
+2 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
IQVIA-DURHAM-6A - IQVIA Holdings Inc, US
Website info
Features
Security
Details
- Company number
- 0824.819.011
- VAT number
- BE 0824.819.011
- Registered office
- Da Vincilaan 7, 1930 Zaventem
- Names & denominations
- REDPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 April 2010
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- redpharma.be
- Activities · NACE
Mediarepresentatie